Phenylketonuria gene therapy (Tome Biosciences)

N/A

Report date: 2024/06/03 16:43:48

Base Information

Drug NamePhenylketonuria gene therapy (Tome Biosciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionPhenylalanine hydroxylase replacementsGene transference
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTome Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTome Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A